SO
VIR icon

STRS Ohio’s Vir Biotechnology VIR Stock Holding History

STRS Ohio’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,500
Closed -$266K – 2038
2023
Q4 		$266K Sell
26,500
-19,500
-42% -$178K ﹤0.01% 1484
2023
Q3 		$431K Buy
46,000
+9,100
+25% +$130K ﹤0.01% 1330
2023
Q2 		$905K Buy
36,900
+1,600
+5% +$40.2K ﹤0.01% 965
2023
Q1 		$821K Buy
35,300
+1,000
+3% +$25.6K ﹤0.01% 1027
2022
Q4 		$868K Sell
34,300
-9,300
-21% -$228K ﹤0.01% 999
2022
Q3 		$840K Buy
43,600
+13,300
+44% +$338K ﹤0.01% 998
2022
Q2 		$771K Buy
30,300
+4,400
+17% +$103K ﹤0.01% 1071
2022
Q1 		$666K Buy
25,900
+5,200
+25% +$154K ﹤0.01% 1310
2021
Q4 		$866K Buy
20,700
+1,200
+6% +$47K ﹤0.01% 1202
2021
Q3 		$848K Buy
19,500
+7,700
+65% +$333K ﹤0.01% 1214
2021
Q2 		$557K Hold
11,800
– – ﹤0.01% 1525
2021
Q1 		$604K Hold
11,800
– – ﹤0.01% 1496
2020
Q4 		$316K Sell
11,800
-4,700
-28% -$153K ﹤0.01% 1641
2020
Q3 		$566K Buy
16,500
+11,600
+237% +$499K ﹤0.01% 1253
2020
Q2 		$200K Buy
4,900
+3,000
+158% +$101K ﹤0.01% 1644
2020
Q1 		$65K Hold
1,900
– – ﹤0.01% 1749
2019
Q4 		$23K Buy
+1,900
New +$25.5K ﹤0.01% 1963

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

STRS Ohio's VIR Position: Q1 2024 in Review

STRS Ohio sold out of Vir Biotechnology (VIR) in Q1 2024, closing a stake of 26,500 shares — an estimated $266K sold.

STRS Ohio first reported a position in VIR in Q4 2019 and held it in 17 quarters. The position peaked at $905K in Q2 2023. 209 funds tracked by Wall St. Rank hold VIR as of Q1 2024.

  • STRS Ohio reported no remaining Vir Biotechnology position as of Q1 2024 after selling out during the quarter.
  • STRS Ohio sold 26,500 Vir Biotechnology shares in Q1 2024, an estimated $266K.
  • STRS Ohio first reported a position in Vir Biotechnology in Q4 2019 and held it in 17 quarters.
  • STRS Ohio's Vir Biotechnology position peaked at $905K in Q2 2023.
  • 209 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2024.

Based on STRS Ohio's 13F filing for Q1 2024, filed 13 May 2024.